Reduced expression of neurofibromin in human meningiomas

British Journal of Cancer

Volumn 76, Issue 6, 1997, Pages 747-756

  Sundaram, V ^a   Lee, J H ^a   Harwalkar, J A ^a   Stein, D J ^a   Roudebush, M ^a   Stacey, D W ^a   Golubic, M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Meningioma; Neurofibromatosis; Neurofibromin; P120 GAP; Tumorigenesis

Indexed keywords

ANTIBODY; GUANOSINE TRIPHOSPHATASE; NEUROFIBROMIN;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LEPTOMENINX; MALE; MENINGIOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030828236     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.456     Document Type: Article

References (47)

1. Arvanits D, Malliri AD, Antoniou D, Linardopoulos S, Field JK and Spandidos DA (1991) Ras p21 expression in brain tumors: Elevated expression in malignant astrocytomas and glioblastoma multiforme. In vivo 5: 317-322
2. Baba H, Fuss B, Urano J, Poullet P, Watson JB, Tamanoi F and Macklin WB (1995) GapIII, a new brain-enriched member of the GTPase-activating protein family. J Neurocsi Res 41: 846-858
3. Ballester R, Marchuk D, Boguski M, Saulino A, Letche R, Wigler M and Collins F (1990) The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63: 851-859
4. Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS and Downward J (1992) Aberrant regulation of ras proteins in tumor cells from type 1 neurofibromatosis patients. Nature 356: 713
5. Bernards A, Haase VH, Murthy AE, Menon A, Hannigan GE and Gusella FJ (1992) Complete human NF1 cDNA sequence: two alternatively spliced mRNAs and absence of expression in a neuroblastoma line. DNA Cell Biol 11: 727-734
6. Bollag G and McCormick F (1991) Differential regulation of rasGAP and neurofibromatosis gene product activities. Nature 351: 576-579
7. Boss JL (1989) Ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689
8. Collins VP, Nordenskjold M and Dumanski JP (1990) The molecular genetics of meningiomas. Brain Pathol 1: 19-24
9. Daston MM, Scrable H, Norlund M, Sturbaum AK, Nissen LM and Ratner N (1992) The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells and oligodendrocytes. Neuron 8: 415-428
10. Declue JE, Papagaeorge AG, Fletcher JA, Diehl SR, Ratner N, Vass WC and Lowy DR (1992) Abnormal regulation of mammalian p21 ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69: 265-273
11. Estes ML, Ransohoff RM, McMahon JT, Jacobs BS and Barna BP (1990) Characterization of adult human astrocytes derived from explant culture. J Neurosci Res 27: 697-705
12. Goluhic M, Roudebush M, Dobrowolski S, Wolfman A and Stacey DW (1992) Catalytic properties, tissue and intracellular distribution of neurofibromin. Oncogene 7: 2151-2159
13. Heim RA, Silverman LM, Farber RA, Kam-Morgan LNW and Luce M (1994) Screening for truncated NF1 proteins. Nature Genet 8: 218-219
14. Kujas M (1993) Meningioma. Current Opin Neurol Neurosurg 6: 882-887
15. Lee JH, Sundaram V, Stein DJ, Kinney SE, Stacey D and Golubic M (1997) Reduced expression of schwannomin/merlin in human sporadic meningiomas. Neurosurgery 40: 578-587
16. Lekanne Deprez RH, Riegman PHJ, Groen NA, Warringa UL, van Biezen NA, Molijn AC, Bootsma D, De Jong PJ, Menon AG, Kley NA, Seizinger BR and Zwarthoff EC (1995) Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meninigioma. Oncogene 10: 1521-1528
17. Li Y, Bollag G, Clark R, Stevens J, Conroy L, Fullts D, Ward K, Friedman E, Samowitz W, Robertson M, Bradley P, McCormick F, White R and Cawthon R (1992) Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69: 275-281
18. Li Y, O'Connell P, Breidenbach HH, Cawthon R, Stevens J, Xu G, Neil S, Robertson M, White R and Viskochil D (1995) Genomic organization of the neurofibromatosis type 1 gene (NF1). Genomics 25: 9-18
19. Lowy DR and Willumsen BM (1993) Function and regulation of ras. Annu Rev Biochem 62: 851-891
20. Lutchman M and Rouleau GA (1996) Neurofibromatosis type 2: a new mechanism of tumor suppression. Trends Neurosci 19: 373-377
21. Maekawa M, Li S, Iwamatsu A, Morishita T, Yokota K, Imai Y, Koshaka S, Nakamura S and Hattori S (1994) A novel mammalian Ras GTPase-activating protein which has phospholipid-binding and Btk homology regions. Mol Cell Biol 14: 6879-6885
22. Maltby EL, Ironside JW and Battersby RDE (1988) Cytogenetic studies in 50 meningiomas. Cancer Genet Cytogenet 31: 199-210
23. Marchuk DA, Saulino AM, Tavakkol R, Swaroop M, Wallace MR, Andersen LB, Mitchekk AL, Gutmann DH, Boguski M and Collins FS (1991) cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 11: 931-940
24. Martuza RL and Eldridge R (1988) Medical progress: neurofibromatosis 2 (bilateral acoustic neurofibromatosis). New Engl J Med 318: 684-688
25. Moodie SA, Paris M, Villafranca E, Kirshmeier P, Willumsen BM and Wolfman A (1995) Different structural requirements with the switch II region of the Ras protein for interactions with specific downstream targets. Oncogene 11: 447-454
26. Mulvihill JJ, Parry DM, Sherman JL, Pikus A, Kaiser-Kupfer MI and Eldridge R (1990) Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). Ann Int Med 113: 39-52
27. Murphy M, Chen J-N and George DL (1991) Establishment and characterization of a human leptomeningeal cell line. J Neurosci Res 30: 475-483
28. Murphy M, Pykett MJ, Harnish P, Zang KD and George DL (1993) Identification and characterization of genes differentially expressed in meningiomas. Cell Growth Diff 4: 725-722
29. O'Rahilly R and Mueller F (1986) The meninges in human development. J Neuropathol Exp Neurol 45: 588-608
30. Peyrard M, Fransson I, Xie Y-G, Han F-Y, Ruttledge MH, Swahn S, Collins JE, Dunham I, Collins VP and Dumanski JP (1994) Characterization of a new member of the human β-adaptin gene family from chromosome 22q12, a candidate meningioma gene. Hum Mol Genet 3: 1393-1399
31. Riccardi VM (1992) Neurofibromatosis: Phenotype, Natural History and Pathogenesis, 2nd edn. pp. 63-85. The Johns Hopkins University Press; Baltimore
32. Rouleau GA, Merel P, Lutchman H, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougaste B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, De Jong P, Parry D, Eldrige R, Aurias A, Delattre O and Thomas G (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 363: 515-520
33. Russel DS and Rubinstein LJ (1989) Tumours of the meninges and related tissues. In Pathology of Tumours of the Nervous System, Russel DS and Rubinstein LJ. (eds), pp. 449-532. Williams & Wilkins: Baltimore
34. Salgaller M, Agius L, Yates A, Pearl D, Roberts W and Stephens R (1990) Application of automated image analysis to demonstrate correlation between Ras p21 expression and seventy of gliomas. Biochem Biophysical Res Comm 169: 482-491
35. Scheithauer BW (1990) Tumors of the meninges: proposed modifications of the World Health Organization classification. Acta Neuropathol 80: 343-354
36. Stacey DW, Feig LA and Gibbs JB (1991) Dominant inhibitory Ras mutants inhibit the activity of either cellular or oncogenic Ras. Mol Cell Biol 11: 4053-4064
37. Stahle-Backdhal M, Inoue M, Zedenius J, Sandstedt B, Demareo L, Flam F, Silfersward C, Andrade J and Freidman E (1995) Decreased expression of Ras GTPase activating protein in human trophoblastic tumors. Am J Pathol 146: 1073-1078
38. Takahashi K, Suzuki H, Hatori M, Abe Y, Kokubun S, Sakurai M and Shibahara S (1995) Reduced expression of neurofibromin in the soft tissue tumours obtained from patients with neurofibromatosis type 1. Clin Sci 88: 581-585
39. Tikoo A, Varga M, Ramesh V, Gusella J and Maruta H (1994) An anti-Ras function of neurofibromatosis type 2 gene product (NF2/merlin). J Biol Chem 269: 23387-23390
40. Todo T, Adams EF, Fahlbush R, Dingermann T and Werner H (1996) Autocrine growth stimulation of human meningioma cells by platelet-derived growth factor. J Neurosurg 84: 852-859
41. Trahey M and McCormick F (1987) A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science 238: 542-545
42. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, Macdonald ME, Seizinger BR, Short MP, Buckler AJ and Gusella JF (1990) A novel meosin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72: 791-800
43. Vogel KS, Brannan CI, Jenkins NA, Copeland NG and Parada LF (1995) Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons. Cell 82: 733-742
44. Von Deimling A, Krone W and Menon GA (1995) Neurofibromatosis type 1: pathology, clinical features and molecular genetics. Brain Pathol 5: 153-162
45. Weisbach L, Settleman J, Kalady MF, Snijders AJ, Murthy AE, Yan Y-X and Bernards A (1994) Identification of a human RasGAP-related protein containing calmodulin-binding motifs. J Biol Chem 269: 20517-20521
46. Xu G, Lin B, Tanaka K, Dunn D, Wood D, Gesteland R, White R, Weiss R and Tamanoi F (1990) The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 63: 835-841
47. Yamada K, Kondo T, Yoshioka M and Oami H (1980) Cytogenetic studies in twenty human brain tumors: association with No. 22 abnormalities with tumours of the brain. Cancer Genet Cytogenet 2: 293-307